Target Price | €25.31 |
Price | €25.36 |
Deviation | 0.18% |
Number of Estimates | 17 |
17 Analysts have issued a price target Commerzbank 2026 . The average Commerzbank target price is €25.31. This is 0.18% lower than the current stock price. The highest price target is €30.00 18.30% , the lowest is €21.50 15.22% . | |
A rating was issued by 19 analysts: 11 Analysts recommend Commerzbank to buy, 7 to hold and 1 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Commerzbank stock has an average upside potential 2026 of 0.18% . Most analysts recommend the Commerzbank stock at Purchase. |
14 Analysts have issued a sales forecast Commerzbank 2025 . The average Commerzbank sales estimate is €11.8b . This is 54.31% lower than the revenue of the last 12 months(TTM). The highest sales forecast is €12.3b 52.27% , the lowest is €11.1b 57.25% .
This results in the following potential growth metrics:
2024 | €26.1b | 15.98% |
---|---|---|
2025 | €11.8b | 54.65% |
2026 | €12.6b | 6.83% |
2027 | €13.3b | 5.70% |
2028 | €13.8b | 3.30% |
11 Commerzbank Analysts have issued a net profit forecast 2025. The average Commerzbank net profit estimate is €2.2b . This is 16.55% lower than the net profit for the last 12 months(TTM). The highest net profit forecast is €2.4b 7.11% , the lowest is €1.8b 31.11% .
This results in the following potential growth metrics and future Net Margins:
2024 | €2.4b | 27.61% |
---|---|---|
2025 | €2.2b | 9.73% |
2026 | €3.4b | 55.26% |
2027 | €4.0b | 20.21% |
2028 | €4.8b | 18.89% |
2024 | 9.21% | 10.03% |
---|---|---|
2025 | 18.33% | 99.10% |
2026 | 26.64% | 45.34% |
2027 | 30.29% | 13.70% |
2028 | 34.87% | 15.12% |
11 Analysts have issued a Commerzbank forecast for earnings per share. The average Commerzbank EPS is €1.88 . This is 16.44% lower than earnings per share in the financial year 2024. The highest EPS forecast is €2.09 7.11% , the lowest is €1.55 31.11% .
This results in the following potential growth metrics and future valuations:
2024 | €2.08 | 27.61% |
---|---|---|
2025 | €1.88 | 9.62% |
2026 | €2.92 | 55.32% |
2027 | €3.50 | 19.86% |
2028 | €4.17 | 19.14% |
Current | 10.81 | 40.94% |
---|---|---|
2025 | 12.94 | 19.70% |
2026 | 8.34 | 35.55% |
2027 | 6.93 | 16.91% |
2028 | 5.83 | 15.87% |
Based on analysts' sales estimates for 2025, the Commerzbank stock is valued at an EV/Sales of 6.65 and an P/S ratio of 2.44 .
This results in the following potential growth metrics and future valuations:
Current | 3.04 | 97.40% |
---|---|---|
2025 | 6.65 | 118.91% |
2026 | 6.23 | 6.39% |
2027 | 5.89 | 5.40% |
2028 | 5.71 | 3.19% |
Current | 1.11 | 44.53% |
---|---|---|
2025 | 2.44 | 118.87% |
2026 | 2.28 | 6.39% |
2027 | 2.16 | 5.39% |
2028 | 2.09 | 3.19% |
Analyst | Rating | Action | Date |
---|---|---|---|
METZLER EQUITIES |
Buy
➜
Buy
|
Unchanged | Mar 31 2025 |
LANDESBANK BADEN-WUERTTEMBERG |
Hold
➜
Hold
|
Unchanged | Mar 30 2025 |
DZ BANK |
Buy
➜
Buy
|
Unchanged | Mar 27 2025 |
HSBC |
Buy
➜
Buy
|
Unchanged | Mar 23 2025 |
WARBURG RESEARCH GMBH |
Buy
➜
Buy
|
Unchanged | Feb 27 2025 |
ODDO BHF |
Buy
➜
Buy
|
Unchanged | Feb 16 2025 |
BNP PARIBAS EXANE |
Outperform
➜
Outperform
|
Unchanged | Jan 05 2025 |
Analyst Rating | Date |
---|---|
Unchanged
METZLER EQUITIES:
Buy
➜
Buy
|
Mar 31 2025 |
Unchanged
LANDESBANK BADEN-WUERTTEMBERG:
Hold
➜
Hold
|
Mar 30 2025 |
Unchanged
DZ BANK:
Buy
➜
Buy
|
Mar 27 2025 |
Unchanged
HSBC:
Buy
➜
Buy
|
Mar 23 2025 |
Unchanged
WARBURG RESEARCH GMBH:
Buy
➜
Buy
|
Feb 27 2025 |
Unchanged
ODDO BHF:
Buy
➜
Buy
|
Feb 16 2025 |
Unchanged
BNP PARIBAS EXANE:
Outperform
➜
Outperform
|
Jan 05 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.